Endodermal sinus (yolk sac) tumors (ESTs) are rare neoplasms that most commonly arise in the ovaries or testis. Only six cases of prostatic ESTs have been reported in the literature. We report a case of prostatic EST, the first case in which the patient had a history of previous testis cancer. Treatment included cisplatin-based chemotherapy and radical prostatectomy. Previous cases of primary ESTs and use of cisplatin-based therapy as well as metastatic tumors to the prostate are discussed.

1.
Benson RC Jr, Segura JW, Carney JA: Primary yolk-sac (endodermal sinus) tumor of the prostate. Cancer 1978;41:1395-1398.
2.
Dalla Palma P, Dante S, Guazzieri S, Sperandio P: Primary endodermal sinus tumor of the prostate: report of a case. Prostate 1988;12:255-261.
3.
Schriber J, Flax S, Trudeau M, Cook GT, Weizel H, Katz A, Keating A: Primary yolk sac (endodermal sinus) tumor of the prostate: case report and review of the literature. Prostate 1990;17:137-143.
4.
Tay HP, Bidair M, Shabaik A, Gilbaugh JH 3rd, Schmidt JD: Primary yolk sac tumor of the prostate in a patient with Klinefelter's syndrome. J Urol 1995;153:1066-1069.
5.
Namiki K, Tsuchiya A, Noda K, Oyama H, Ishibashi K, Kusama H, Furusato M: Extragonadal germ cell tumor of the prostate associated with Klinefelter's syndrome. Int J Urol 1999;6:158-161.
6.
Sato S, Shinohara N, Harabayashi T, Nonomura K, Koyanagi T: Testicular nonseminomatous germ cell cancer presenting with metastasis to prostate and seminal vesicles. BJU Int 2002;90(4cr):472.
7.
Michel F, Gattegno B, Roland J, Coloby P, Colbert N, Thibault P: Primary nonseminomatous germ cell tumor of the prostate. J Urol 1986;135:597-599.
8.
Khandekar JD, Holland JM, Rochester D, Christ ML: Extragonadal seminoma involving urinary bladder and arising in the prostate. Cancer 1993;71:3972-3974.
9.
Hayman R, Patel A, Fisher C, Hendry WF: Primary seminoma of the prostate. Br J Urol 1995;76:273-274.
10.
Sell S, Pierce GB: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994;70:6-22.
11.
Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A, Pinkerton CR, Shepherd JH, Gallagher C, Slevin M, Harper P, Osborne R, Mansi J, Oliver T, Gore ME: Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 1999;85:2232-2244.
12.
Han G, Miura K, Takayama T, Tsutsui Y: Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma. Am J Surg Pathol 2003;27:554-559.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.